PubMed · 4104779
The source did not provide an abstract. Follow the original record for more information.
Explore connections, maps & timelines
1971-07-31. Medicines commission.. https://pubmed.ncbi.nlm.nih.gov/4104779/
Cite the original work for its findings. Save a collection to share your selection of sources.
KEEP EXPLORING
The origins of the Pharmacy and Therapeutics (P&T) Committee is intertwined with the evolution of the modern practice of pharmacy. Although the P&T Committee has been uniquely developed to help make coverage decisions, this implies that its technology assessment function, particularly with regard to medicines, has paved the way to more cost-effective and evidence-based practice. This article, which briefly traces the lineage of the first known "formulary" employed during the Revolutionary War to today's P&T Committee, argues that its true function--technology assessment--serves as the basis for coverage decisions throughout health systems.
Traditionally, pharmacy and therapeutics (P&T) committees have been responsible for overseeing the drug use process, using formulary systems to control drug costs. Primarily, these committees act in an advisory capacity as policy-recommending bodies within healthcare systems, for the specific purpose of promoting rational drug therapy. Methodologies utilised by these committees include drug use evaluation, medical staff education, continuous quality improvement, formulary restriction and therapeutic interchange. Future roles of P&T committees will include the evaluation of clinical outcomes information, including quality-of-life issues, to establish policies governing the use of drugs at all levels and in all types of healthcare.
Explore the source record for details and available documents.